Do changes in policy affect vaccine coverage levels? Results of a national study to evaluate childhood vaccination coverage and reasons for missed vaccination in ItalyDEGLI ATTI, M. L; ROTA, Maria Cristina; BELLA, Antonino et al.Vaccine. 2004, Vol 22, Num 31-32, pp 4351-4357, issn 0264-410X, 7 p.Article

Surveillance of perceptions, knowledge, attitudes and behaviors of the Italian adult population (18―69 years) during the 2009―2010 A/H1N1 influenza pandemicFERRANTE, Gianluigi; BALDISSERA, Sandro; MOGHADAM, Pirous Fateh et al.European journal of epidemiology. 2011, Vol 26, Num 3, pp 211-219, issn 0393-2990, 9 p.Article

Resurgence of pertussis in EuropePASTORE CELENTANO, Lucia; MASSARI, Marco; PARAMATTI, Daniele et al.The Pediatric infectious disease journal. 2005, Vol 24, Num 9, pp 761-765, issn 0891-3668, 5 p.Article

Duration of immunity against pertussis after natural infection or vaccinationWENDELBOE, Aaron M; VAN RIE, Annelies; SALMASO, Stefania et al.The Pediatric infectious disease journal. 2005, Vol 24, Num 5, pp s58-s61, issn 0891-3668, SUPArticle

Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of lifeTOZZI, Alberto E; RAVA, Lucilla; DEGLI ATTI, Marta L et al.Pediatrics (Evanston). 2003, Vol 112, Num 5, pp 1069-1075, issn 0031-4005, 7 p.Article

Pediatric sentinel surveillance of vaccine-preventable diseases in ItalyCIOFI DEGLI ATTI, Marta Luisa; SALMASO, Stefania; BELLA, Antonino et al.The Pediatric infectious disease journal. 2002, Vol 21, Num 8, pp 763-768, issn 0891-3668Article

Antibody kinetics and long-term sero-prevalence in the Italian clinical trial of acellular pertussis vaccinesGIULIANO, M; MASTRANTONIO, P; GIAMMANCO, A et al.Developments in biological standardization. 1997, Num 89, pp 275-278, issn 0301-5149Conference Paper

Methods for estimating serological correlates of protectionSIBER, G. R.Developments in biological standardization. 1997, Num 89, pp 283-296, issn 0301-5149Conference Paper

Preparation and composition of acellular pertussis vaccines. Consideration of potential effects on vaccine efficacyHEWLETT, E. L.Developments in biological standardization. 1997, Num 89, pp 143-151, issn 0301-5149Conference Paper

Assessment of measles incidence, measles-related complications and hospitalisations during an outbreak in a southern Italian regionCIOFI DEGLI ATTI, Marta Luisa; FILIA, Antonietta; MASSARI, Marco et al.Vaccine. 2006, Vol 24, Num 9, pp 1332-1338, issn 0264-410X, 7 p.Article

Bordetella pertussis serotype of clinical isolates in Sweden during 1970-1995 and influence of vaccine efficacy studiesTIRU, M; ASKELÖF, P; GRANSTRÖM, M et al.Developments in biological standardization. 1997, Num 89, pp 239-245, issn 0301-5149Conference Paper

Diagnostic pertussis serology in the recent clinical efficacy studies of acellular vaccinesHALLANDER, H. O.Developments in biological standardization. 1997, Num 89, pp 205-212, issn 0301-5149Conference Paper

Differences by antigen in seroconversion : Sensitivity, specificity and bias in the serological confirmation of pertussisWASSILAK, S. G. F; ANEMONA, A; GIULIANO, M et al.Developments in biological standardization. 1997, Num 89, pp 221-228, issn 0301-5149Conference Paper

Epidemiological determinants of pertussisMILLER, E; GAY, N. J.Developments in biological standardization. 1997, Num 89, pp 15-23, issn 0301-5149Conference Paper

Epidemiology of pertussis and use of acellular pertussis vaccines in JapanKUNO-SAKAI, H; KIMURA, M.Developments in biological standardization. 1997, Num 89, pp 331-332, issn 0301-5149Conference Paper

Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccineSCHMITT-GROHE, S; STEHR, K; CHERRY, J. D et al.Developments in biological standardization. 1997, Num 89, pp 113-118, issn 0301-5149Conference Paper

Safety of acellular pertussis vaccine : Follow-up studiesCHEN, R. T.Developments in biological standardization. 1997, Num 89, pp 373-375, issn 0301-5149Conference Paper

Serological responses to infection with B. pertussisGIAMMANCO, A; TAORMINA, S; GENOVESE, M et al.Developments in biological standardization. 1997, Num 89, pp 213-220, issn 0301-5149Conference Paper

The Senegal pertussis trial : Safety and surveillance of adverse reactionsPREZIOSI, M.-P; NDIAYE, M; COLL-SECK, A et al.Developments in biological standardization. 1997, Num 89, pp 91-97, issn 0301-5149Conference Paper

The United States research strategy on pertussisLA MONTAGNE, J. R.Developments in biological standardization. 1997, Num 89, pp 25-28, issn 0301-5149Conference Paper

Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic periodRIZZO, Caterina; ROTA, Maria Cristina; MONTOMOLI, Emanuele et al.Vaccine. 2010, Vol 28, Num 20, pp 3558-3562, issn 0264-410X, 5 p.Article

Neuropsychological Performance 10 Years After Immunization in Infancy With Thimerosal-Containing VaccinesEUGENIO TOZZI, Alberto; BISIACCHI, Patrizia; TARANTINO, Vincenza et al.Pediatrics (Evanston). 2009, Vol 123, Num 2, pp 475-482, issn 0031-4005, 8 p.Article

Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in ItalyD'ANCONA, Fortunato; SALMASO, Stefania; BARALE, Antonella et al.Vaccine. 2005, Vol 23, Num 19, pp 2494-2500, issn 0264-410X, 7 p.Article

A consideration of control requirements for acellular pertussis vaccinesCORBEL, M. J; XING, D. K. L.Developments in biological standardization. 1997, Num 89, pp 343-347, issn 0301-5149Conference Paper

Absolute efficacy of acellular pertussis vaccines in household settingsSTORSAETER, J; GUSTAFSSON, L.Developments in biological standardization. 1997, Num 89, pp 153-158, issn 0301-5149Conference Paper